Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 40 of 114

  1. EXPAREL 13.3Mg/mL Suspension for Injection

    Pacira Ireland Limited

    Bunion

    phase 3 small molecule terminated

    1 trial

  2. EXPAREL 266 mg

    Pacira Ireland Limited

    Posterolateral Thoracotomy

    phase 3 small molecule completed

    1 trial

  3. Ear pills

    Universal Integrated

    Intradialytic Hypotension

    phase 3 small molecule active

    1 trial

  4. Early Vasopressin

    Chongqing Precision Biotech Co., Ltd

    Septic Shock

    phase 3 small molecule active

    1 trial

  5. Early activity and mobilisation

    Zealand Pharma A/S

    Critically Ill, Mechanically Ventilated

    phase 3 other completed

    1 trial

  6. Eculizumab

    Alexion Europe SAS

    Neuromyelitis Optica

    phase 3 small molecule terminated

    2 trials

  7. Edotecarin

    Pfizer

    Glioblastoma

    phase 3 small molecule completed

    1 trial

  8. Edoxaban

    Daiichi Sankyo

    Cardiac Disease

    phase 3 small molecule completed

    1 trial

  9. Educational Dementia training

    United Therapeutics Europe Ltd

    Dementia

    phase 3 other active

    1 trial

  10. Educational Intervention

    United Therapeutics Europe Ltd

    Hematologic Malignancies

    phase 3 other active

    1 trial

  11. Efgartigimod PH20 SC

    argenx

    Primary Sjogrens Disease

    phase 3 mab active

    1 trial

  12. Efgartigimod, Placebo for efgartigimod

    argenx

    Thyroid Eye Disease (TED)

    phase 3 small molecule active

    1 trial

  13. Eicosapentaenoic Acid and Docosahexaenoic Acid (EPA + DHA)

    United Therapeutics Europe Ltd

    Cardiovascular Disease

    phase 3 mab completed

    1 trial

  14. Elaprase 2 mg/ml concentrate for solution for infusion

    Denali Therapeutics

    Mucopolysaccharidosis Type II [MPS II]

    phase 3 small molecule active

    1 trial

  15. Elective nodal irradiation (ENI)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Esophageal Squamous Cell Carcinoma

    phase 3 other active

    1 trial

  16. Elenestinib

    Blueprint Medicines (Netherlands) B.V.

    Indolent Systemic Mastocytosis

    phase 3 small molecule active

    1 trial

  17. Eloralintide

    Eli Lilly and Company

    Obesity

    phase 3 small molecule active

    1 trial

  18. Elritercept

    Takeda

    Myelodysplastic Syndrome

    phase 3 small molecule active

    1 trial

  19. Eltrombopag

    GlaxoSmithKline

    Non-alcoholic Steatohepatitis

    phase 3 small molecule terminated

    1 trial

  20. Eltrombopag 25 MG Oral Tablet

    The First People's Hospital of Lianyungang

    Stem Cell Transplant Complications

    phase 3 small molecule completed

    1 trial

  21. Emicizumab

    Takeda

    Hemophilia A

    phase 3 small molecule active

    1 trial

  22. Emixustat

    BRIGHT MINDS BIOSCIENCES INC.

    Stargardt Disease

    phase 3 small molecule completed

    1 trial

  23. Empagliflozin

    Boehringer Ingelheim

    Myocardial Infarction

    phase 3 small molecule completed

    1 trial

  24. Empagliflozin

    Boehringer Ingelheim

    Heart Failure

    phase 3 small molecule completed

    1 trial

  25. Empagliflozin

    Boehringer Ingelheim

    Chronic Kidney Disease

    phase 3 small molecule active

    1 trial

  26. Empagliflozin 10 MG

    Hospital Authority, Hong Kong

    Diabetic Nephropathies

    phase 3 small molecule terminated

    1 trial

  27. Empagliflozin 10 MG

    COLLEGIUM PHARMACEUTICAL, INC

    Acute Decompensated Heart Failure

    phase 3 small molecule active

    1 trial

  28. Empagliflozin 10 mg

    United Therapeutics Europe Ltd

    Acute Myocardial Infarction

    phase 3 small molecule completed

    1 trial

  29. Empagliflozin 20 mg

    COLLEGIUM PHARMACEUTICAL, INC

    Metabolic Syndrome

    phase 3 small molecule active

    1 trial

  30. Empowered Relief On-Demand

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    phase 3 other completed

    1 trial

  31. Enbrel solution for injection in pre-filled s... for Chronic Plaque Psoriasis

    Janssen-Cilag International N.V.

    Chronic Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  32. Encaleret

    BridgeBio Oncology Therapeutics

    Autosomal Dominant Hypocalcemia (ADH)

    phase 3 small molecule active

    2 trials

  33. Encaleret

    BridgeBio Oncology Therapeutics

    Autosomal Dominant Hypocalcemia Type 1 (ADH1)

    phase 3 small molecule active

    1 trial

  34. Endoscopic submucosal dissection

    United Therapeutics Europe Ltd

    Colorectal Neoplasms

    phase 3 other active

    1 trial

  35. Endoscopic submucosal dissection

    Chinese University of Hong Kong

    Colorectal Neoplasms

    phase 3 other active

    1 trial

  36. Endostar

    The First People's Hospital of Lianyungang

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  37. Enhanced care

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Addiction

    phase 3 other completed

    1 trial

  38. Enhanced standard management

    United Therapeutics Europe Ltd

    Pacemaker Complication

    phase 3 other active

    1 trial

  39. Enoxaparin

    Bristol-Myers Squibb

    Deep Vein Thrombosis

    phase 3 small molecule completed

    1 trial

  40. Enoxaparin sodium (XRP4563)

    Sanofi Pasteur

    Myocardial Infarction

    phase 3 small molecule completed

    1 trial

  41. Entecavir

    Bristol-Myers Squibb

    Hepatitis B, Chronic

    phase 3 small molecule completed

    1 trial

  42. Entecavir

    Hoffmann-La Roche

    Pediatric Immuno-Tolerant Chronic Hepatitis B

    phase 3 small molecule completed

    1 trial

  43. Enzalutamide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Metastatic Hormone Sensitive Prostate Cancer

    phase 3 small molecule active

    1 trial

  44. Enzastaurin

    AYTU BIOPHARMA, INC

    Vascular Ehlers-Danlos Syndrome

    phase 3 small molecule on hold

    1 trial

  45. Epetraborole

    AN2 Therapeutics

    MAC Lung Disease

    phase 3 small molecule terminated

    1 trial

  46. Epidyolex 100 mg/ml oral solution

    Lacuna Pharma Pty Ltd

    Dravet Syndrome, Tuberous sclerosis complex, Lennox-Gastaut Syndrome

    phase 3 small molecule active

    1 trial

  47. Epinephrine

    Chinese University of Hong Kong

    Gastric Neoplasm

    phase 3 small molecule completed

    1 trial

  48. Epinephrine HFA-MDI (E004)

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.